196 related articles for article (PubMed ID: 32962414)
1. Autosomal dominant retinitis pigmentosa with toxic gain of function: Mechanisms and therapeutics.
Narasimhan I; Murali A; Subramanian K; Ramalingam S; Parameswaran S
Eur J Ophthalmol; 2021 Mar; 31(2):304-320. PubMed ID: 32962414
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147
[No Abstract] [Full Text] [Related]
3. Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
Meng D; Ragi SD; Tsang SH
Mol Ther; 2020 Oct; 28(10):2139-2149. PubMed ID: 32882181
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa.
Waseem NH; Vaclavik V; Webster A; Jenkins SA; Bird AC; Bhattacharya SS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1330-4. PubMed ID: 17325180
[TBL] [Abstract][Full Text] [Related]
5. Course of Ocular Function in PRPF31 Retinitis Pigmentosa.
Hafler BP; Comander J; Weigel DiFranco C; Place EM; Pierce EA
Semin Ophthalmol; 2016; 31(1-2):49-52. PubMed ID: 26959129
[TBL] [Abstract][Full Text] [Related]
6. Phenotype associated with mutation in the recently identified autosomal dominant retinitis pigmentosa KLHL7 gene.
Hugosson T; Friedman JS; Ponjavic V; Abrahamson M; Swaroop A; Andréasson S
Arch Ophthalmol; 2010 Jun; 128(6):772-8. PubMed ID: 20547956
[TBL] [Abstract][Full Text] [Related]
7. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
[TBL] [Abstract][Full Text] [Related]
8. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.
Dryja TP; McGee TL; Hahn LB; Cowley GS; Olsson JE; Reichel E; Sandberg MA; Berson EL
N Engl J Med; 1990 Nov; 323(19):1302-7. PubMed ID: 2215617
[TBL] [Abstract][Full Text] [Related]
9. A new codon 15 rhodopsin gene mutation in autosomal dominant retinitis pigmentosa is associated with sectorial disease.
Sullivan LJ; Makris GS; Dickinson P; Mulhall LE; Forrest S; Cotton RG; Loughnan MS
Arch Ophthalmol; 1993 Nov; 111(11):1512-7. PubMed ID: 8240107
[TBL] [Abstract][Full Text] [Related]
10. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
Mitra RN; Zheng M; Weiss ER; Han Z
Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa.
Kajiwara K; Hahn LB; Mukai S; Travis GH; Berson EL; Dryja TP
Nature; 1991 Dec; 354(6353):480-3. PubMed ID: 1684223
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic expression of autosomal dominant retinitis pigmentosa in a Swedish family expressing a Phe-211-Leu variant of peripherin/RDS.
Ekström U; Ponjavic V; Abrahamson M; Nilsson-Ehle P; Andrëasson S; Stenström I; Ehinger B
Ophthalmic Genet; 1998 Mar; 19(1):27-37. PubMed ID: 9587927
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of a previously undescribed codon 216 (proline to serine) mutation in the peripherin/retinal degeneration slow gene in autosomal dominant retinitis pigmentosa.
Fishman GA; Stone E; Gilbert LD; Vandenburgh K; Sheffield VC; Heckenlively JR
Ophthalmology; 1994 Aug; 101(8):1409-21. PubMed ID: 8058286
[TBL] [Abstract][Full Text] [Related]
14. Characterization of RP1L1, a highly polymorphic paralog of the retinitis pigmentosa 1 (RP1) gene.
Bowne SJ; Daiger SP; Malone KA; Heckenlively JR; Kennan A; Humphries P; Hughbanks-Wheaton D; Birch DG; Liu Q; Pierce EA; Zuo J; Huang Q; Donovan DD; Sullivan LS
Mol Vis; 2003 Apr; 9():129-37. PubMed ID: 12724644
[TBL] [Abstract][Full Text] [Related]
15. Novel mutations in the 3-box motif of the BACK domain of KLHL7 associated with nonsyndromic autosomal dominant retinitis pigmentosa.
Oh JK; Lima de Carvalho JR; Sun YJ; Ragi S; Yang J; Levi SR; Ryu J; Bassuk AG; Mahajan VB; Tsang SH
Orphanet J Rare Dis; 2019 Dec; 14(1):295. PubMed ID: 31856884
[TBL] [Abstract][Full Text] [Related]
16. The nature of dominant mutations of rhodopsin and implications for gene therapy.
Wilson JH; Wensel TG
Mol Neurobiol; 2003 Oct; 28(2):149-58. PubMed ID: 14576453
[TBL] [Abstract][Full Text] [Related]
17. Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65.
Choi EH; Suh S; Sander CL; Hernandez CJO; Bulman ER; Khadka N; Dong Z; Shi W; Palczewski K; Kiser PD
Hum Mol Genet; 2018 Jul; 27(13):2225-2243. PubMed ID: 29659842
[TBL] [Abstract][Full Text] [Related]
18. Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa.
Sudharsan R; Beltran WA
Adv Exp Med Biol; 2019; 1185():113-118. PubMed ID: 31884598
[TBL] [Abstract][Full Text] [Related]
19. Autosomal dominant macular degeneration associated with 208delG mutation in the FSCN2 gene.
Wada Y; Abe T; Itabashi T; Sato H; Kawamura M; Tamai M
Arch Ophthalmol; 2003 Nov; 121(11):1613-20. PubMed ID: 14609921
[TBL] [Abstract][Full Text] [Related]
20. Retinitis pigmentosa and related disorders: phenotypes of rhodopsin and peripherin/RDS mutations.
Shastry BS
Am J Med Genet; 1994 Oct; 52(4):467-74. PubMed ID: 7747760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
